Tech Company M&A Transactions
Lotus Tissue Repair Acquisition
Headquartered in Cambridge, Lotus Tissue Repair was acquired by Shire Pharmaceuticals. What Shire Pharmaceuticals paid for Lotus Tissue Repair was not announced.
Transaction Overview
Company Name
Acquired By
Announced On
1/9/2013
Transaction Type
M&A
Amount
Unknown
M&A Terms
Shire will purchase the company for an upfront payment and certain contingent payments based on the achievement of certain safety and development milestones.
Company Information
Company Status
Acquired or Merged
Industry
Medical Devices & Instruments
Mailing Address
One Mifflin Place 400
Cambridge, MA 02138
USA
Cambridge, MA 02138
USA
Phone
Website
Email Address
Overview
Lotus Tissue Repair is developing its proprietary recombinant human collagen Type VII (rC7) technology as a treatment for dermatologic conditions in which rC7 may play an important role in accelerating chronic wound healing, such as diabetic foot ulcers, venous stasis ulcers and similar conditions.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Mark Souza
Chief Financial Officer
James Fordyce
Chief Medical Officer
Philip Reilly
Browse more venture capital transactions:
Prev: 1/9/2013: Mobiplex venture capital transaction
Next: 1/9/2013: Revance Therapeutics venture capital transaction
Share this article
Where The Data Comes From
We do our best to record every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs